Raj Parekh, Ph.D.
Raj Parekh is a General Partner of Advent Life Sciences. He joined Advent in 2005, bringing over 20 years of experience as an entrepreneur and investor in the life sciences. Prior to joining Advent, Raj was a Director at Celldex Therapeutics, and before that, he was Chairman of Chroma Therapeutics and of Galapagos nv. Previously, Raj co-founded Oxford GlycoSciences, which became listed on the LSE and NASDAQ and was later acquired by UCT-Celltech. He began his career in academia, in molecular medicine at the University of Oxford. Raj received a Ph.D., an MA and a BA in Biochemistry and Molecular Medicine, all from the University of Oxford.
Raj has served on the boards of directors of several portfolio companies, including Thiakis, Avila, EUSA and Cellnovo.